Table 2.

Characteristics of currently available single-bag peritoneal dialysis (PD) solutions [19]

	Manufacturer	Potential drawbacks	Potential benefits
Lactate-buffered glucose containing Dianeal®	Baxter	Low pH	Ease of manufacture; low cost
		High GDP content
		Poor peritoneal membrane biocompatibility
		Infusion pain
		Local and systemic glucose exposure
Icodextrin-containing; lactate buffered	Baxter	Hypersensitivity	Sustained ultrafiltration
		Low pH	Preservation of RRF
		Licensed for single daily use only	Hypertonic glucose replacement
		Lactate containing	Reduced hyperglycemia
			Improved short-term systemic hemodynamic profile
			Desirable effects on metabolic profile and body composition
Amino-acid containing; Nutrineal®	Baxter	Low pH	No GDPs
		Licensed for single daily use only (avoid exacerbation of uremic symptoms and acidosis)	Avoid systemic and peritoneal glucose exposure
			Peritoneal membrane protection
			Enhance nutrition

GDP glucose degradation product, RRF residual renal function